2023 - Research.com Microbiology in France Leader Award
Gilles Pialoux focuses on Immunology, Internal medicine, Acquired immunodeficiency syndrome, Virology and Hepatitis C virus. Immunology is often connected to Disease in his work. His research in Internal medicine intersects with topics in Gastroenterology, Viral load and Emtricitabine.
Gilles Pialoux has researched Emtricitabine in several fields, including Men who have sex with men, Pre-exposure prophylaxis and Ritonavir. His work in the fields of Acquired immunodeficiency syndrome, such as Sida, overlaps with other areas such as Circulating MicroRNA. When carried out as part of a general Virology research project, his work on Outbreak is frequently linked to work in Aedes albopictus, therefore connecting diverse disciplines of study.
Gilles Pialoux mostly deals with Internal medicine, Immunology, Virology, Acquired immunodeficiency syndrome and Gastroenterology. His work deals with themes such as Ribavirin, Hepatitis C virus and Viral load, which intersect with Internal medicine. His study in Hepatitis C virus is interdisciplinary in nature, drawing from both Cirrhosis and Hepatitis C.
His study involves Viral disease, Virus, Immunogenicity, CD8 and Immune system, a branch of Immunology. The study incorporates disciplines such as Protease inhibitor and Antibody in addition to Virology. His Gastroenterology study frequently draws parallels with other fields, such as Pathology.
The scientist’s investigation covers issues in Internal medicine, Men who have sex with men, Pre-exposure prophylaxis, Cohort and Prospective cohort study. Gilles Pialoux has included themes like Antibody, Hepatitis C virus and Emtricitabine in his Internal medicine study. His Hepatitis C virus research is multidisciplinary, incorporating perspectives in Hepatitis C and Polymorphism.
His Pre-exposure prophylaxis study integrates concerns from other disciplines, such as Interquartile range, Logistic regression, Pill and One year follow up. His biological study spans a wide range of topics, including Antiretroviral therapy, Proportional hazards model, Hiv transmission and Hazard ratio. His Prospective cohort study research includes elements of Observational study, Unsafe Sex and Retrospective cohort study.
His main research concerns Internal medicine, Prospective cohort study, Logistic regression, Antibody and Emtricitabine. His Internal medicine research is multidisciplinary, incorporating elements of Virus and Drug resistance. His Prospective cohort study study combines topics from a wide range of disciplines, such as Intensive care medicine, Disease transmission, Tenofovir and Economic evaluation.
In his research, Risk factor, Acquired immunodeficiency syndrome, Viral hepatitis, Hyperintensity and Viral load is intimately related to Odds ratio, which falls under the overarching field of Logistic regression. Many of his research projects under Antibody are closely connected to Respiratory disease with Respiratory disease, tying the diverse disciplines of science together. His studies in Emtricitabine integrate themes in fields like Men who have sex with men, Pre-exposure prophylaxis, Incidence, Sexual intercourse and Pill.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study
Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka.
PLOS ONE (2015)
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
Abstr Act;C. Capitant;B. Spire;G. Pialoux.
The New England Journal of Medicine (2015)
Chikungunya, an epidemic arbovirosis.
Gilles Pialoux;Bernard-Alex Gaüzère;Stéphane Jauréguiberry;Michel Strobel.
Lancet Infectious Diseases (2007)
Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.
Fabrice Carrat;Firouzé Bani-Sadr;Stanislas Pol;Eric Rosenthal.
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
Alison J Rodger;Valentina Cambiano;Tina Bruun;Pietro Vernazza.
The Lancet (2019)
Mechanisms of Virologic Failure in Previously Untreated HIV-Infected Patients From a Trial of Induction-Maintenance Therapy
D Descamps;P Flandre;V Calvez;G Peytavin.
Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy
Caroline Besson;Aicha Goubar;Jean Gabarre;Willy Rozenbaum.
Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy.
Ana Canestri;Franæois-Xavier Lescure;Stephane Jaureguiberry;Antoine Moulignier.
Clinical Infectious Diseases (2010)
Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study
Jean-Michel Molina;Jean-Michel Molina;Isabelle Charreau;Bruno Spire;Laurent Cotte.
The Lancet HIV (2017)
Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study).
Eric Rosenthal;Marilyne Poirée;Christian Pradier;Christian Perronne.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: